Cargando…

Stem cell therapy for insulin-dependent diabetes: Are we still on the road?

In insulin-dependent diabetes, the islet β cells do not produce enough insulin and the patients must receive exogenous insulin to control blood sugar. However, there are still many deficiencies in exogenous insulin supplementation. Therefore, the replacement of destroyed functional β cells with insu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Lu, Hu, Zhu-Meng, Jiang, Fang-Xu, Wang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2022
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350623/ https://www.ncbi.nlm.nih.gov/pubmed/36157527 http://dx.doi.org/10.4252/wjsc.v14.i7.503

Ejemplares similares

Induction Therapy for Kidney Transplant Recipients: Do We Still Need Anti‐IL2 Receptor Monoclonal Antibodies?
por: Hellemans, R., et al.
Publicado: (2016)

Still 'dwelling in the possibility' - critical update on stem cell therapy for acute on chronic liver failure
por: Philips, Cyriac Abby, et al.
Publicado: (2020)

Progress and expectation of stem cell therapy for diabetic wound healing
por: Xu, Zhen-Han, et al.
Publicado: (2023)

Insulin resistance in diabetes: The promise of using induced pluripotent stem cell technology
por: Elsayed, Ahmed K, et al.
Publicado: (2021)

Clinical and pathophysiological understanding of the hepatorenal syndrome: Still wrong or still not exactly right?
por: Wilde, Benjamin, et al.
Publicado: (2023)

COVID-19 and the liver: Are footprints still there?
por: Gupta, Tarana, et al.
Publicado: (2023)

Role of selenium in type 2 diabetes, insulin resistance and insulin secretion
por: Casanova, Pilar, et al.
Publicado: (2023)

Progress and prospect of stem cell therapy for diabetic erectile dysfunction
por: Luo, Dao-Sheng, et al.
Publicado: (2021)

Combination therapy of hydrogel and stem cells for diabetic wound healing
por: Huang, Jia-Na, et al.
Publicado: (2022)

Yeast osmoregulation – glycerol still in pole position
por: Blomberg, Anders
Publicado: (2022)

Stem cell therapy and diabetic erectile dysfunction: A critical review
por: Pakpahan, Cennikon, et al.
Publicado: (2021)

Place of technosphere inhaled insulin in treatment of diabetes
por: Mikhail, Nasser
Publicado: (2016)

Lymphocytic esophagitis: Still an enigma a decade later
por: Rouphael, Carol, et al.
Publicado: (2017)

Hiding the road signs that lead to tumor immunity
por: Schaer, David A., et al.
Publicado: (2011)

Between evidence and new perspectives on the current state of the multimodal approach to gastric cancer: Is there still a role for radiation therapy?
por: Agolli, Linda, et al.
Publicado: (2018)

Status, challenges, and future prospects of stem cell therapy in pelvic floor disorders
por: Cheng, Juan, et al.
Publicado: (2020)

Gastric cancer in 2022: Is there still a role for endoscopic ultrasound?
por: Rossi, Gemma, et al.
Publicado: (2023)

Genetic heterogeneity in breast cancer: the road to personalized medicine?
por: Baird, Richard D, et al.
Publicado: (2013)

Roads to the development of improved pertussis vaccines paved by immunology
por: Brummelman, Jolanda, et al.
Publicado: (2015)

Hyperkalemia: Major but still understudied complication among heart transplant recipients
por: Singh, Jagmeet, et al.
Publicado: (2021)

Neural stem cell therapy for brain disease
por: Zhao, Lan, et al.
Publicado: (2021)

Will he still look good with the lights on? Spectral tuning of visual pigments in fish
por: Jones, Julia C, et al.
Publicado: (2008)

Enhanced endoscopic ultrasound imaging for pancreatic lesions: The road to artificial intelligence
por: Spadaccini, Marco, et al.
Publicado: (2022)

New role for ceramide in hypoxia and insulin resistance
por: Xia, Qing-Song, et al.
Publicado: (2020)

Adipose-derived stem cell therapy shows promising results for secondary lymphedema
por: Hu, Li-Ru, et al.
Publicado: (2020)

Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate
por: Faccia, Mariella, et al.
Publicado: (2019)

Role of insulin and insulin resistance in androgen excess disorders
por: Unluhizarci, Kursad, et al.
Publicado: (2021)

Diabetes and COVID-19: Role of insulin resistance as a risk factor for COVID-19 severity
por: Gangadharan, Charitha, et al.
Publicado: (2021)

Advanced glycation end productions and tendon stem/progenitor cells in pathogenesis of diabetic tendinopathy
por: Shi, Liu, et al.
Publicado: (2021)

Clinical potentials of ginseng polysaccharide for treating gestational diabetes mellitus
por: Zhao, Xuan-Yin, et al.
Publicado: (2021)

Angiogenesis inhibitors in clinical development; where are we now and where are we going?
por: Eskens, F A L M
Publicado: (2004)

Endoscopic therapy for Barrett’s esophagus and early esophageal cancer: Where do we go from here?
por: Singh, Tavankit, et al.
Publicado: (2018)

Exercise therapy for sarcopenia and diabetes
por: Lim, Seung-Taek, et al.
Publicado: (2023)

Similar but Still Different: Which Amino Acid Residues Are Responsible for Varying Activities in Type‐III Copper Enzymes?
por: Kampatsikas, Ioannis, et al.
Publicado: (2020)

Clinical application of stem cell therapy in Parkinson's disease
por: Politis, Marios, et al.
Publicado: (2012)

We and herbivores eat endophytes
por: Martínez‐Romero, Esperanza, et al.
Publicado: (2020)

Immunity to SARS-CoV-2: What Do We Know and Should We Be Testing for It?
por: Misra, Anisha, et al.
Publicado: (2022)

Liver stem cells: Plasticity of the liver epithelium
por: Tsuchiya, Atsunori, et al.
Publicado: (2019)

Review of operative considerations in spinal cord stem cell therapy
por: Upadhyayula, Pavan S, et al.
Publicado: (2021)

Targeting mesenchymal stem cell therapy for severe pneumonia patients
por: Lam, Guy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1uvff392neoanpoblqfjslmaq2